Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
MA17.07 Durvalumab Plus Anlotinib Versus Durvalumab as Maintenance Treatment in ES-SCLC (DURABLE): A Randomized, Phase 2 Trial
Bo Han, Bin Zhang, Zhong Ren, Chengbin Shi, Paul Kim Ho Chu, Jianliang Zhang, H. Wang, Yuliang Zhao, Gang Xin, Zhi Zhang, Wei Su, Jie Li, Hao Zhong (2024). MA17.07 Durvalumab Plus Anlotinib Versus Durvalumab as Maintenance Treatment in ES-SCLC (DURABLE): A Randomized, Phase 2 Trial. , 19(10), DOI: https://doi.org/10.1016/j.jtho.2024.09.225.
Article11 days agoMA17.07 Durvalumab Plus Anlotinib Versus Durvalumab as Maintenance Treatment in ES-SCLC (DURABLE): A Randomized, Phase 2 Trial
Bo Han, Bin Zhang, Zhong Ren, Chengbin Shi, Paul Kim Ho Chu, Jianliang Zhang, H. Wang, Yuliang Zhao, Gang Xin, Zhi Zhang, Wei Su, Jie Li, Hao Zhong (2024). MA17.07 Durvalumab Plus Anlotinib Versus Durvalumab as Maintenance Treatment in ES-SCLC (DURABLE): A Randomized, Phase 2 Trial. , 19(10), DOI: https://doi.org/10.1016/j.jtho.2024.09.225.
Article11 days ago